Meanwhile, we found that the expression level of several immune-checkpoint molecules, including CTLA-4, IDO1, LAG3, CD274, PD-1, PD-L2, TIGIT, and HAVCR2 were significantly positively associated with cytolytic activity in glioma. Here, PDCD1LG2 is linked to central nervous system cancer.